Literature DB >> 32531328

The functions of LncRNA in the heart.

Yao Wang1, Xianglan Sun2.   

Abstract

Cardiovascular disease is a major cause of death and disability worldwide. Recently, increasing evidence has demonstrated that various lncRNAs play critical roles in the pathogenesis of cardiovascular diseases, including myocardial ischemia and reperfusion (I/R) injury. LncRNAs are transcripts longer than 200 nucleotides. They are considered a class of dynamic noncoding RNAs known to be involved in physiological and pathological conditions with regulatory and structural roles in numerous biological processes, including genomic imprinting, epigenetic regulation, cell proliferation, development, aging and apoptosis. They are emerging as potential key regulators of a variety of cardiovascular diseases. However, the roles of lncRNAs in the heart function remain largely unknown. The purpose of this review was to summarize the functions of lncRNAs in the heart and discuss the challenges and possible strategies of lncRNA research for cardiovascular disease.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Function; Heart diseases; LncRNAs

Year:  2020        PMID: 32531328     DOI: 10.1016/j.diabres.2020.108249

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

1.  LncRNA XR_595552 inhibition alleviates intermittent hypoxia-induced cardiomyocyte damage via activating the PI3K/AKT pathway.

Authors:  Qingshi Chen; Dandan Guo; Guofu Lin; Mengxue Chen; Jiefeng Huang; Qichang Lin
Journal:  Sleep Breath       Date:  2022-02-23       Impact factor: 2.816

2.  LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p/CCND1 axis.

Authors:  Hui Kang; Hui Yu; Ling Zeng; Hao Ma; Ge Cao
Journal:  Hypertens Res       Date:  2022-03-09       Impact factor: 3.872

Review 3.  Non-Coding RNAs: New Dawn for Diabetes Mellitus Induced Erectile Dysfunction.

Authors:  Wenchao Xu; Hongyang Jiang; Jihong Liu; Hao Li
Journal:  Front Mol Biosci       Date:  2022-06-22

4.  Targeting Circulating lncRNA ENST00000538705.1 Relieves Acute Coronary Syndrome via Modulating ALOX15.

Authors:  Hao Chen; Shiwei Huang; Fanlu Guan; Sisi Han; Fanhao Ye; Xun Li; Liyi You
Journal:  Dis Markers       Date:  2022-05-06       Impact factor: 3.464

Review 5.  Non-coding RNAs modulate autophagy in myocardial ischemia-reperfusion injury: a systematic review.

Authors:  Fuwen Huang; Jingting Mai; Jingwei Chen; Yinying He; Xiaojun Chen
Journal:  J Cardiothorac Surg       Date:  2021-05-22       Impact factor: 1.637

Review 6.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 7.  Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-12       Impact factor: 6.832

8.  Prognostic Value of a Pyroptosis-Related Long Noncoding RNA Signature Associated with Osteosarcoma Microenvironment.

Authors:  Xinxin Bu; Jiuxiang Liu; Rong Ding; Zhi Li
Journal:  J Oncol       Date:  2021-11-11       Impact factor: 4.375

9.  RNA Sequencing of Cardiac in a Rat Model Uncovers Potential Target LncRNA of Diabetic Cardiomyopathy.

Authors:  Yangbo Xi; Dongping Chen; Zhihui Dong; Hingcheung Lam; Jiading He; Keyi Du; Can Chen; Jun Guo; Jianmin Xiao
Journal:  Front Genet       Date:  2022-04-13       Impact factor: 4.772

Review 10.  Long Noncoding RNAs: Recent Insights into Their Role in Male Infertility and Their Potential as Biomarkers and Therapeutic Targets.

Authors:  Shanjiang Zhao; Nuo Heng; Bahlibi Weldegebriall Sahlu; Huan Wang; Huabin Zhu
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.